Generate Biomedicines develops protein-based medicines using Generative Biology® and The Generate Platform™.
Products & media
An investigational anti-TSLP antibody being studied for severe asthma and COPD, engineered for extended duration between doses.
An investigational MUC16-targeted, IL-18-armored CAR T-cell therapy in development for metastatic ovarian cancer.
An openly available generative model and software toolkit for designing protein structures and sequences with programmable constraints.
An investigational antibody designed to bind free MMAE and reduce systemic toxicity when used alongside MMAE-based antibody-drug conjugates.
A generative protein design platform used in research collaborations to create and experimentally optimize new therapeutic proteins.
Team
Founders
2 people
Jobs
See all jobs for Generate Biomedicines here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Leads
Participating Firms
Angels
